These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5714265)

  • 41. [Malignant lymphoma in rheumatoid arthritis treated by low doses of methotrexate].
    Taillan B; Garnier G; Ferrari E; Castanet J; Pesce A; Fuzibet JG; Dujardin P
    Rev Rhum Ed Fr; 1993 Mar; 60(3):248-50. PubMed ID: 8293012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggressive drug therapy for rheumatoid arthritis.
    McGuire JL; Ridgway WM
    Hosp Pract (Off Ed); 1993 Sep; 28(9):45-52. PubMed ID: 8366157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis].
    Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S
    An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Storb R; Thomas ED
    N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477182
    [No Abstract]   [Full Text] [Related]  

  • 46. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    van de Rijn M; Kamel OW
    N Engl J Med; 1995 Dec; 333(23):1568; author reply 1568-9. PubMed ID: 7477181
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rheumatoid arthritis: a new basic therapy. Proliferating T-cells controlled].
    MMW Fortschr Med; 2000 Apr; 142(17):51. PubMed ID: 10879025
    [No Abstract]   [Full Text] [Related]  

  • 48. [Experience with local immunosuppressive therapy in rheumatoid arthritis].
    Julkunen H
    Z Rheumaforsch; 1969; 28(1):5-7. PubMed ID: 5810413
    [No Abstract]   [Full Text] [Related]  

  • 49. Back to the future: the managed care approach to rheumatoid arthritis.
    Sidorov J
    Manag Care Interface; 2007 Jul; 20(7):28-30. PubMed ID: 17849731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
    Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W
    Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti B cell therapy proves successful in severe cases of rheumatoid arthritis.
    Marshall HE
    Trends Immunol; 2001 Jan; 22(1):13-4. PubMed ID: 11286684
    [No Abstract]   [Full Text] [Related]  

  • 53. Early rheumatoid arthritis in the USSR and in Finland.
    Martio J; Kiviniemi P; von Essen R; Isomäki H; Akimova T; Ievleva L; Trofimova T; Mylov N
    Scand J Rheumatol; 1980; 9(1):39-43. PubMed ID: 7375870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Altered pharmacokinetics and dosage of antirheumatics, corticosteroids, cytostatics and immunosuppressives in renal insufficiency].
    Vlaho M; Gross R
    Internist (Berl); 1981 Oct; 22(10):629-35. PubMed ID: 7028665
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis].
    Pascual Gómez E
    Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis].
    Talpaz M
    Harefuah; 1980; 98(10):468-71. PubMed ID: 7450579
    [No Abstract]   [Full Text] [Related]  

  • 57. New therapeutics in rheumatoid arthritis.
    Savage C; St Clair EW
    Rheum Dis Clin North Am; 2006 Feb; 32(1):57-74, viii. PubMed ID: 16504821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.
    van Roon JA; Jacobs K; Verstappen S; Bijlsma J; Lafeber F
    Ann Rheum Dis; 2008 Jul; 67(7):1054-5. PubMed ID: 18556451
    [No Abstract]   [Full Text] [Related]  

  • 59. Contemporary management of rheumatoid arthritis.
    Horwitz H; Conte J
    Med Health R I; 1999 Sep; 82(9):316-20. PubMed ID: 10517075
    [No Abstract]   [Full Text] [Related]  

  • 60. [The future form of cytostatico-immunosuppressive therapy of rheumatoid arthritis].
    Jesserer H
    Verh Dtsch Ges Inn Med; 1968; 74():116-20. PubMed ID: 5714265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.